Natera Inc News - NTRA | ADVFN

S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Natera Inc (NTRA)

167.60

7.00

(4.36%)

Closed 05 January 8:00AM

Delayed by 15 minutes

167.00

-0.60

(-0.36%)

After Hours: 11:18AM

Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Court Grants Natera’s Request to Include Additional Patent in its Lawsuit Against NeoGenomics

Amended complaint asserts infringement of U.S. Patent Nos. ‘596 and ‘454 by the modified version of NeoGenomics’ RaDaR assay Natera, Inc...

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Natera Announces Enrollment of First Patients in SAGITTARIUS: a Randomized, Phase III Clinical Trial in Colon Cancer

SAGITTARIUS is Natera's first interventional trial using SignateraTM to select patients for targeted therapy in early-stage colon cancer...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

1
Next

PonkenPlonken

PonkenPlonken 2 months ago

now biggest pstn at Duquesne

Monksdream

Monksdream 5 months ago

NTRA new 52 week high

Monksdream

Monksdream 5 months ago

NTRA new 52=week high

Monksdream

Monksdream 5 months ago

NTRA new 52 week high

Monksdream

Monksdream 7 months ago

Pioneers in individualized genetic testing

Cell-free DNA (cfDNA) can be found in everyone. Not only do our own cells release it, so do fetal, tumor, and donor organ cells. Using a simple blood draw, our technology precisely detects each of these types of cell-free DNA, uniquely for each individual, to help proactively inform their treatment.
With more than 15 years of experience focused in this field, our technology has been used to perform more cell-free DNA tests than any other.

Monksdream

Monksdream 10 months ago

NTRA new 52 week high

Monksdream

Monksdream 10 months ago

NTRA new 52 week high

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions